Neumora Therapeutics Inc (NMRA)

Finanzdaten der Neumora Therapeutics Inc-Aktie (NMRA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	20.19%42.19	52.86	58.48	57.70	54.04
Research and Development	24.13%29.28	38.60	44.67	40.52	38.72
Interest Income/Expense	0.70%1.43	1.44	-	-	-
Operating Income/Loss	20.19%-42.19	-52.86	-58.48	-57.70	-54.04
Nonoperating Income/Loss	58.16%-0.89	-0.56	-0.97	0.95	1.33
Income/Loss From Continuing Operations Before Tax	19.36%-43.08	-53.43	-59.45	-56.76	-52.71
Income Tax Expense/Benefit	100.00%-	0.03	-	-	0.03
	19.41%-43.08	-53.46	-59.45	-56.76	-52.73
Attributable To Parent	19.41%-43.08	-53.46	-59.45	-56.76	-52.73
Basic Average Shares	2.94%185.16	179.87	-	161.84	161.69
Diluted Average Shares	2.94%185.16	179.87	-	161.84	161.69
Basic Earnings Per Share	23.33%-0.23	-0.30	-	-0.35	-0.33
Diluted Earnings Per Share	23.33%-0.23	-0.30	-	-0.35	-0.33